Examples of 'etravirine' in a sentence
Meaning of "etravirine"
Etravirine (noun) - a medication used in the treatment of HIV infection
Show more definitions
- A particular drug used for the treatment of HIV.
How to use "etravirine" in a sentence
Basic
Advanced
etravirine
Etravirine is expected to increase plasma concentrations of diazepam.
Sensitivity of the virus to etravirine at screening was required.
That etravirine may inhibit the metabolism of.
Dexamethasone is expected to decrease plasma concentrations of etravirine.
Etravirine significantly reduced plasma concentrations of dolutegravir.
Medicinal products that affect etravirine exposure.
Etravirine is expected to increase plasma concentrations of warfarin.
No interaction between pravastatin and etravirine is expected.
Etravirine may decrease plasma concentrations of letermovir.
No dose adjustment required for raltegravir or etravirine.
Etravirine is expected to increase nelfinavir plasma concentrations.
There are no pharmaceutical companies manufacturing generic etravirine.
Unchanged etravirine was not detected in urine.
Intelence is a medicine containing the active substance etravirine.
Carcinogenicity studies of etravirine in rodents are ongoing.
See also
Etravirine without boosted protease inhibitors.
No human data on the effect of etravirine on fertility are available.
Etravirine on dolutegravir plasma concentrations was mitigated by.
It is not known whether etravirine is excreted in human milk.
Etravirine was not carcinogenic in rats and in male mice.
In vitro data show that etravirine has inhibitory.
Etravirine is primarily metabolised and eliminated by the liver.
Medicinal products that are affected by the use of etravirine.
Etravirine is only approved for.
It contains the active substance etravirine.
Etravirine is also a weak inhibitor of.
There is no specific antidote for overdose with etravirine.
Etravirine is excreted in human milk.
Rash has been reported with etravirine.
Etravirine without boosted protease inhibitors decreased plasma dolutegravir concentration.
Rifampicin and rifapentine are expected to decrease plasma concentrations of etravirine.
Etravirine can be used with these NRTIs without dose adjustment.
The active substance is etravirine.
Etravirine is expected to decrease.
The differences were less pronounced for unbound etravirine exposure.
Etravirine is only approved for use with boosted protease inhibitors.
Intelence is a medicine that contains the active substance etravirine.
In vitro and in vivo studies with etravirine revealed no evidence of a mutagenic potential.
Recommended indication for etravirine.
The pharmacokinetics of etravirine have not been studied in patients with renal insufficiency.
Severe cutaneous adverse reactions have been reported with etravirine.
Concomitant use of etravirine with simeprevir may decrease plasma concentrations of simeprevir.
Risk of decrease in etravirine.
Etravirine is primarily metabolised and eliminated by the liver and highly bound to plasma proteins.
The reductions in etravirine.
Etravirine is very insoluble in aqueous media and therefore suffers from very low bioavailability.
Mg twice daily etravirine.
The present inventors have developed a simple and commercially viable process for synthesis of etravirine.
Mg once daily etravirine.
These adverse reactions have been identified through postmarketing experience with etravirine.
